Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000041858 | SCV000065554 | likely benign | not specified | 2017-10-24 | criteria provided, single submitter | clinical testing | p.Val1803Val in exon 27 of USH2A: This variant is not expected to have clinical significance because it does not alter an amino acid residue, is not located wit hin the splice consensus sequence, and has been identified in 0.1% (148/126184) of European chromosomes by the Genome Aggregation Database (gnomAD, http://gnoma d.broadinstitute.org/; dbSNP rs140326085). |
Labcorp Genetics |
RCV000879979 | SCV001023037 | likely benign | not provided | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000879979 | SCV001830569 | likely benign | not provided | 2021-02-04 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000041858 | SCV002819805 | likely benign | not specified | 2022-12-24 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000879979 | SCV004125617 | likely benign | not provided | 2024-07-01 | criteria provided, single submitter | clinical testing | USH2A: BP4, BP7 |
Genome- |
RCV003450852 | SCV004181811 | likely benign | Retinitis pigmentosa 39 | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001276248 | SCV004181812 | likely benign | Usher syndrome type 2A | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001276248 | SCV001462256 | likely benign | Usher syndrome type 2A | 2020-09-16 | no assertion criteria provided | clinical testing |